We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
US Physical Therapy Inc | NYSE:USPH | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 101.83 | 0 | 09:09:52 |
|
|
|
||
(State or other jurisdiction
of incorporation or organization)
|
(Commission
File Number)
|
(I.R.S. Employer
Identification No.)
|
|
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
Emerging growth company
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
|
◻
|
Exhibits
|
Description of Exhibits
|
|
Registrant's Press Release dated May 7, 2024
|
U.S. PHYSICAL THERAPY, INC.
|
|||||||
Dated: May 7, 2024
|
By:
|
/s/ CAREY HENDRICKSON
|
|||||
Carey Hendrickson
|
|||||||
Chief Financial Officer
|
|||||||
(duly authorized officer and principal financial and accounting officer)
|
•
|
Adjusted EBITDA (1), a non-Generally Accepted Accounting Principles (“GAAP”) measure, was $16.7 million for the first quarter
ended March 31, 2024 (“2024 First Quarter”) compared to $18.5 million in the first quarter ended March 31, 2023 (“2023 First Quarter”), with the variance due to the Medicare rate reductions that took effect at the beginning of 2024 and the
impact of significant adverse weather events in January 2024. The Medicare rate reductions decreased Adjusted EBITDA by approximately $1.7 million while the adverse weather resulted in a decrease in Adjusted EBITDA of approximately $1.3
million.
|
•
|
Operating Results (1), a non-GAAP measure, was $7.7 million in each of the 2024 First Quarter and 2023 First Quarter. On a
per share basis, Operating Results was $0.51 in the 2024 First Quarter compared to $0.59 in the 2023 First Quarter, with the decrease attributable to the increase in shares outstanding associated with the Company’s secondary offering
completed in May 2023. The impact of the Medicare rate reduction and weather on 2024 First Quarter Operating Results was approximately $2.2 million, or $0.15 per share.
|
•
|
Net income attributable to USPH’s shareholders (“USPH net income”), a GAAP measure, was $8.0 million for the 2024 First Quarter compared
to $7.4 million for the 2023 First Quarter. In accordance with GAAP, the revaluation of redeemable non-controlling interest, net of taxes, is not included in net income but is charged directly to retained earnings; however, this change is
included in the computation of earnings per share. Earnings per share for the 2024 First Quarter was $0.46 compared to $0.58 for the 2023 First Quarter.
|
•
|
Total revenue from physical therapy operations for the 2024 First Quarter increased $5.3 million, or 4.1%, to $134.4 million.
|
•
|
Net rate per patient visit for the 2024 First Quarter increased to $103.37 from $103.12 for the 2023 First Quarter despite the 3.5%
Medicare rate reduction in effect for most of the 2024 First Quarter. The increase in net rate per patient visit reflects the Company’s strategic priority of increasing reimbursement rates through contract negotiations with commercial and
other payors as well as growth in workers compensation as percent of the Company’s overall mix of business.
|
•
|
Average daily visits per clinic was 29.5 for the 2024 First Quarter compared to 29.8 in the comparable prior year quarter. Total patient
visits were 1,268,002 in the 2024 First Quarter, a 3.3% increase from 2023 First Quarter. Average daily visits per clinic in January 2024 of 27.4 were lower than the prior year of 28.9, while average daily visits per clinic in February and
March of 2024 were higher than the prior year, the highest volumes for those two months in the Company’s history.
|
•
|
Industrial injury prevention (“IIP”) services revenue was $21.3 million for the 2024 First Quarter, an increase of 9.8% as compared to
the 2023 First Quarter, with an increase in gross profit of 15.1%.
|
•
|
During the 2024 First Quarter, the Company added 14 new clinics, including the acquisition described below, and closed six clinics
bringing its total clinic count to 679 as of March 31, 2024, as compared to 647 clinics as of March 31, 2023.
|
•
|
On March 29, 2024, the Company acquired a 50% equity interest in a nine-clinic practice for a purchase price of $16.4 million, with the
original practice owners retaining a 50% equity interest. The acquired business currently generates approximately $11.4 million in annual revenues and approximately 65,000 annual visits.
|
•
|
On April 30, 2024, one of the Company’s primary IIP businesses, Briotix Health Limited Partnership, acquired 100% of an IIP services
business for a purchase price of $24.0 million. The acquired business currently generates approximately $11.0 million in annual revenues.
|
•
|
The Company’s Board of Directors declared a quarterly dividend of $0.44 per share payable on June 14, 2024, to shareholders of record on
May 23, 2024.
|
•
|
Management increased full-year guidance and now expects Adjusted EBITDA for 2024 to be in the range of $82.5 million to $87.5 million.
See “Management Updates 2024 Guidance” below for more information.
|
(1)
|
See pages 11 and 12 of this release for the definition and reconciliation of non-GAAP measures,
Adjusted EBITDA and Operating Results, to the most directly comparable GAAP measure.
|
U.S. Physical Therapy Press Release
|
Page 2
|
May 7, 2024
|
|
Document and Entity Information |
May 07, 2024 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | May 07, 2024 |
Entity File Number | 001-11151 |
Entity Registrant Name | U S PHYSICAL THERAPY INC /NV |
Entity Central Index Key | 0000885978 |
Entity Incorporation, State or Country Code | NV |
Entity Tax Identification Number | 76-0364866 |
Entity Address, Address Line One | 1300 WEST SAM HOUSTON PARKWAY |
Entity Address, Address Line Two | SUITE 300 |
Entity Address, City or Town | HOUSTON |
Entity Address, State or Province | TX |
Entity Address, Postal Zip Code | 77043 |
City Area Code | 713 |
Local Phone Number | 297-7000 |
Title of 12(b) Security | Common Stock, $.01 par value |
Trading Symbol | USPH |
Security Exchange Name | NYSE |
Entity Emerging Growth Company | false |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
1 Year US Physical Therapy Chart |
1 Month US Physical Therapy Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions